# Ipratropium + Salbutamol

## Combivent UDV 2.5mL

| TAH Drug Code      | [ECOMU](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ECOMU)                                                                                                                                                                                                                                                                                                                                                |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Management of reversible bronchospasm associated with obstructive airways diseases in patients who require more than a single bronchodilator.                                                                                                                                                                                                                                                                         |
| Dosing             | Adult 1-2 inhalations BID-QID. [Micromedexs 2021/06/11] Asthma: >12years moderate to severe asthma every 4- 6hours 1 unit dose, severe asthma every 20 minutes use 1 unit dose for 3 times as needed for up to 3hours. 0-12year severe asthma every 20 minutes use 0.5- 1 unit dose for 3 times as needed for up to 3hours. COPD requring second bronchodilator 1 inhalation QID. Maximum: 6 inhalations in 24 hours. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                         |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                         |
| Contraindications  | Hypertrophic obstructive cardiomyopathy or tachyarrhythmia                                                                                                                                                                                                                                                                                                                                                            |
| Adverse Effects    | Headache, dizziness, nervousness, tachycardia, fine tremor, palpitations. Potentially serious hypokalaemia may result from Î²2 agonist therapy. Dry mouth, dysphonia, ocular complications, allergic-type reactions.                                                                                                                                                                                                   |
| Pregnancy          | Human Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                           |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                         |
| More Info          | [UpToDate](https://www.uptodate.com/contents/ipratropium-and-salbutamol-drug-information)                                                                                                                                                                                                                                                                                                                             |

